No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
To investigate whether glucocorticoids can rapidly improve symptoms and shorten the course of disease in patients with atypical pathogen pneumonia.
This was a retrospective observational study. A total of 105 patients with atypical pathogen pneumonia admitted to our hospital from May 2023 to May 2025 were enrolled. They were divided into a glucocorticoid group and a non-glucocorticoid group according to whether glucocorticoids were used, and the clinical effects were compared between the two groups.
Symptom improvement, length of hospital stay and hospitalization costs: There were no significant differences in the time to fever resolution, length of hospital stay and hospitalization costs between the glucocorticoid group and the non-glucocorticoid group, with no statistically significant difference between groups (P > 0.05).
Glucocorticoids cannot rapidly improve clinical symptoms, shorten hospital stay or reduce hospitalization costs in the treatment of atypical pathogen pneumonia.